CAS: 808-26-4; (4S,4As,5Ar,12As)-4-(Dimethylamino)-3,10,12,12A-Tetrahydroxy-1,11-Dioxo-1,4,4A,5,5A,6,11,12A-Octahydrotetracene-2-Carboxamide

该化合物是一种半合成四环环产物,具有广谱抗菌活动,对克菌阳性和克菌阴性细菌以及某些非典型病原体具有有效功效;通过可逆的与30-S核子元素结合,抑制细菌蛋白合成的复合功能;主要优势包括:与早期四环相比,稳定性得到加强,对细菌抗药性机制的易感性降低,以及有利于药动因的特性,如口服生物利用率提高; 桑cy林还表明,与其他四环菌类抗生素相比,光毒性较低,胃肠侧效应减少,其结构改变有助于扩大治疗抗感染的临床效用,同时保持特征清晰的安全特征.

结构式图片

上下游产品

CAS号5679-00-5 7-二去甲基米诺环素

合成工艺路线路线简述

  • 127-33-3 = 808-26-4
    反应条件:1.1 Reagents: Hydrogen Catalysts: Palladium Solvents: Ethanol; 6 H,40 °C
    标题:Synthesis And Neuroprotective Activity Of Novel C4,C7 Derivatives In Tetracycline Series
    作者:Zhou,Zhan-Yun; Et Al
    参考文献:Journal Of Chinese Pharmaceutical Sciences 日期:2004 卷标:13(3) 页码:217-220
地美环素置于10% Rhodium On Carbon,氢气,对甲苯磺酸体系中,用 甲醇 作为反应溶剂,20.0 °C,2.5 Mpa 条件下,反应 15.0H,以88%的收率获得产物山环素
参考文献:一种山环素的制备方法
标题:一种山环素的制备方法
摘要:本发明公开了一种山环素的制备方法,其包括下列步骤:醇和酸的混合溶剂中,氢气环境下,在催化剂的作用下,将化合物i进行反应,得到化合物ii即可;所述的醇为c1~c6的醇;所述的酸为硫酸,氢溴酸,甲磺酸,对甲苯磺酸,高氯酸和重量百分比为85%磷酸中的一种或多种.本发明的制备方法收率高,反应副产物少,纯度高,工艺过程简捷,后处理简单,溶剂和催化剂能够回收,环保压力小,成本低廉,适合于工业化生产.

海关参考信息

专利信息


专利号:US-9688644-B2
优先权日:2009-04-30
标 题 :Synthesis of Tetracyclines and intermediates thereto
发明人:MYERS ANDREW G; KUMMER DAVID A; LI DERUN; HECKER EVAN; DION AMELIE; WRIGHT PETER M
权利人:HARVARD COLLEGE
摘要:The tetracycline class of antibiotics has played a major role in the treatment of infectious diseases for the past 50 years. However, the increased use of the tetracyclines in human and veterinary medicine has led to resistance among many organisms previously susceptible to tetracycline antibiotics. The recent development of a modular synthesis of tetracycline analogs through a chiral enone intermediate has allowed for the efficient synthesis of novel tetracycline analogs never prepared before. The present invention provides more efficient routes for preparing the enone intermediate and allows for substituents at positions 4a, 5, 5a, and 12a of the tetracycline ring system.

专利号:US-9884830-B2
优先权日:2004-05-21
标题 :Synthesis of tetracyclines and analogues thereof
发明人:MYERS ANDREW G; CHAREST MARK G; LERNER CHRISTIAN D; BRUBAKER JASON D; SIEGEL DIONICIO R
权利人:HARVARD COLLEGE
摘要:The tetracycline class of antibiotics has played a major role in the treatment of infectious diseases for the past 50 years. However, the increased use of the tetracyclines in human and veterinary medicine has led to resistance among many organisms previously susceptible to tetracycline antibiotics. The modular synthesis of tetracyclines and tetracycline analogs described provides an efficient and enantioselective route to a variety of tetracycline analogs and polycyclines previously inaccessible via earlier tetracycline syntheses and semi-synthetic methods. These analogs may be used as anti-microbial agents or anti-proliferative agents in the treatment of diseases of humans or other animals.

专利号:US-8907104-B2
优先权日:2006-10-11
标 题 :Synthesis of enone intermediate
发明人:MYERS ANDREW G; BRUBAKER JASON D
权利人:HARVARD COLLEGE
摘要:The tetracycline class of antibiotics has played a major role in the treatment of infectious diseases for the past 50 years. However, the increased use of the tetracyclines in human and veterinary medicine has led to resistance among many organisms previously susceptible to tetracycline antibiotics. The recent development of a modular synthesis of tetracycline analogs through a chiral enone intermediate has allowed for the efficient synthesis of novel tetracycline analogs never prepared before. The present invention provides a more efficient route for preparing the enone intermediate.

专利号:US-8486921-B2
优先权日:2006-04-07
标 题:Synthesis of tetracyclines and analogues thereof
发明人:MYERS ANDREW G; BRUBAKER JASON D; SUN CUIXIANG; WANG QIU
权利人:MYERS ANDREW G; BRUBAKER JASON D; SUN CUIXIANG; WANG QIU; HARVARD COLLEGE
摘要:The tetracycline class of antibiotics has played a major role in the treatment of infectious diseases for the past 50 years. However, the increased use of the tetracyclines in human and veterinary medicine has led to resistance among many organisms previously susceptible to tetracycline antibiotics. The modular synthesis of tetracyclines and tetracycline analogs described provides an efficient and enantioselective route to a variety of tetracycline analogs and polycyclines previously inaccessible via earlier tetra-cycline syntheses and semi-synthetic methods. These analogs may be used as anti-microbial agents or anti-pro liferative agents in the treatment of diseases of humans or other animals.

专利号:US-9982005-B2
优先权日:2013-04-04
标 题 :Macrolides and methods of their preparation and use
发明人:MYERS ANDREW G; SEIPLE IAN BASS; ZHANG ZIYANG
权利人:HARVARD COLLEGE
摘要:Provided herein are methods of preparing macrolides by the coupling of an eastern and western half, followed by macrocyclization, to provide macrolides, including both known and novel macrolides. Intermediates in the synthesis of macrolides including the eastern and western halves are also provided. Pharmaceutical compositions and methods of treating infectious diseases and inflammatory conditions using the inventive macrolides are also provided. A general diastereoselective aldol methodology used in the synthesis of the western half is further provided.

专利号:US-11466046-B2
优先权日:2014-10-08
标题 :14-membered ketolides and methods of their preparation and use
发明人:MYERS ANDREW G; SEIPLE IAN BASS; ZHANG ZIYANG
权利人:HARVARD COLLEGE
摘要:Provided herein are methods of preparing new 14-membered ketolides via coupling of an eastern and western half moiety, followed by macrocyclization, and optional functionalization. Intermediates in the synthesis of these ketolides including the eastern and western halves are also provided. Pharmaceutical compositions and methods of treating infectious diseases and inflammatory conditions using these ketolides are also provided.
宁波天泽新材料科技有限公司
⚠️ 未注册 · 未认证企业
⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
数据来源于公开网络搜索,平台未作核实,请自行辨别。
🏢敬请 企业认领
🏬开设公司展台
📢获取免费会员权益
🎖️点亮专属注册企业标签
📇展现公司完整信息 样本查看立即注册认领 →
网址: http://www.agracechem.com
电话: 0574-87621641👤
📞宁波天泽新材料科技有限公司 ⚠️参考联系方式

销售电话:0574-87621641
邮箱:Tianze@agracechem.com
🆔 联系时候可告知是从"百琢研"平台获取的信息.
⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

⚠️ 未注册 · 未认证企业
注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别 ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
第 1 / 1 页
现货

供应商参考报价(招募中)

品牌试剂参考报价(招募中)

📌 第三方产品分析报告

✅ COA系统入驻 | 共享模式

主要参考文献


1: Cao Q, Liu C, Li Y, Qin Y, Wang C, Wang T. The underlying mechanisms of oxytetracycline degradation mediated by gut microbial proteins and metabolites in Hermetia illucens. Sci Total Environ. 2024 Oct 10;946:174224. doi: 10.1016/j.scitotenv.2024.174224. Epub 2024 Jun 22. 27(11):3645. doi: 10.3390/molecules27113645.
3: Fares M, Oerther S, Hultenby K, Gubrianska D, Zhao Y, Abedi-Valugerdi M, Hassan M. COL-3-Induced Molecular and Ultrastructural Alterations in K562 Cells. J Pers Med. 2022 Jan 4;12(1):42. doi: 10.3390/jpm12010042.
4: Goenka S, Simon SR. Comparative study of doxycycline, sancycline, and 4-dedimethylamino sancycline (CMT-3) on epidermal melanogenesis. Arch Dermatol Res. 2023 Mar;315(2):249-257. doi: 10.1007/s00403-021-02297-w. Epub 2021 Nov 9. 450(1-2):225-34. doi: 10.1016/j.ijpharm.2013.04.021. Epub 2013 Apr 20. 68(15):5838-51. doi: 10.1021/jo030047d. Erratum in: J Org Chem. 2003 Dec 26;68(26):10199. 22(13):2775-81. doi: 10.1002/1522-2683(200108)22:13<2775::AID-ELPS2775>3.0.CO;2-2. 181(1):31-40. doi: 10.1016/s0378-5173(98)00417-7. 88(5):535-7. doi: 10.1021/js980398l. 13(7):905-10. doi: 10.1016/0731-7085(95)01330-n. 74(2):225-30. 33(3):193-210. doi: 10.1016/0162-0134(88)80049-7. 34(7):1065-71. doi: 10.1016/0006-2952(85)90610-0.

合成参考文献


摘要:S6 | ITNANTIBIOTIC | Antibiotic List from the ITN MSCA ANSWER | DOI:10.5281/zenodo.2621956
摘要:Kleemann, A.; Engel, J.; Kutscher, B.; Reichert, D., Pharmaceutical Substances[Online], Thieme: Stuttgart, (2019)
摘要:Kleemann, A.; Engel, J.; Kutscher, B.; Reichert, D., Pharmaceutical Substances[Online], Thieme: Stuttgart, (2003).
摘要:Trauner, D., Science of Synthesis, (2008) 32, 541.
📝 需求与反馈
尽可能描述清楚需求与问题信息
×

通知